Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 882 of 5804
-
New yellow fever vaccine shows promise in japanese adults
⭐️ VACCINE ⭐️ CompletedThe purpose of this study is to assess the safety and immunogenicity of vYF in adults aged 18 years and over in Japan. Study details include: * The study duration will be up to approximately 1 month. * One single dose of vYF will be administrated subcutaneously at the 1st visit…
Phase: PHASE3 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 09:01 UTC
-
Genetic blueprint of tumors may guide smarter cancer treatment
Knowledge-focused Recruiting nowA total of 550 patients with metastatic solid tumors or primary CNS malignancy will be recruited on a first come first serve basis at one of the 14 participating centers : UZL, UZG, Imelda, ZAZ, AZ Klina, CHU Liège, GHdC, CHU UCL Namur, IJB, UZB, CUSL, UZA, VITAZ and Jessa Zh.. …
Sponsor: The Belgian Society of Medical Oncology • Aim: Knowledge-focused
Last updated Jul 22, 2026 00:00 UTC
-
Nose zap might stop migraines before they start
Prevention Recruiting nowThis is a prospective, randomized, open-label, delayed-start clinical investigation evaluating the safety and efficacy of the Walther System, a Class IIa investigational medical device delivering intra-nasal mechanical stimulation (INMEST), as a preventative treatment for migrain…
Phase: NA • Sponsor: Abilion Medical Systems AB • Aim: Prevention
Last updated Jun 27, 2026 08:03 UTC
-
Could a Once-Daily pill prevent deadly clots in cancer patients?
Disease control Recruiting nowBlood clots, also known as venous thromboembolism (VTE), are a common and serious complication for people with cancer. They can lead to pain, hospitalizations, delayed cancer treatment, and even death. Although national guidelines recommend using blood thinners (anticoagulants) t…
Phase: PHASE3 • Sponsor: University of Vermont • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
FDA-Approved MASH drug gets Real-World test in pakistan
Disease control Recruiting nowPhase 4 clinical trial study aims to further evaluate the safety and therapeutic efficacy of Resmetirom in Pakistani patients with fibroscan proven MASH.
Phase: PHASE4 • Sponsor: Nabiqasim Industries (Pvt) Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Engineered immune cells take on Hard-to-Treat cancers
Disease control Recruiting nowThis is a single-arm, open-label, Phase I study to evaluate the safety, tolerability, and antitumor activity of TX103 CAR-T cells in subjects with TX103-positive advanced solid tumors. The study also aims to explore the maximum tolerated dose (MTD) and determine the recommended P…
Phase: PHASE1 • Sponsor: Tcelltech Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Can writing help heal teen trauma? new trial aims to find out
Symptom relief Recruiting nowThis study aims to examine the effectiveness of group Guided Written Exposure Therapy for Complex Post-Traumatic Stress Disorder (GWE-C) among Chinese adolescents through a randomized controlled trial. A total of 120 participants will be recruited, with 60 randomized to the GWE-C…
Phase: NA • Sponsor: Peking University • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC
-
Sound waves vs. tumors: new device aims to zap pain without surgery
Symptom relief Not yet recruitingWhen solid tumors cause pain or other symptoms due to compression or mass effect, and surgical resection is not feasible, the primary clinical recommendation for malignant tumors is chemotherapy or local radiotherapy to delay tumor progression, improve quality of life, and prolon…
Phase: NA • Sponsor: National Taiwan University Hospital • Aim: Symptom relief
Last updated Jun 26, 2026 17:36 UTC
-
Could special glasses stop nearsightedness from getting worse?
Disease control ENROLLING_BY_INVITATIONThe purpose of the study is to quantify the effectiveness of Hoya MiyoSmart IQ (DIMS-TED) spectacle lenses in slowing the rate of myopia progression in university students.
Phase: NA • Sponsor: University of Bradford • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Less surgery may be just as good for advanced melanoma after immunotherapy
Disease control Recruiting nowThe goal of this clinical trial is to demonstrate that there is no difference (non-inferiorty) in the 2 year recurrence-free survival (RFS) between 2 different surgical approaches for clinical Stage III melanoma. Following 6 weeks of standard neaodjuvant immunotherapy, patients w…
Phase: NA • Sponsor: Melanoma Institute Australia • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New hope for teen depression? drug trial targets symptoms in japanese youth
Symptom relief Recruiting nowThe main aim of the study is to check how well vortioxetine 10 mg/day or 20 mg/day works and to check for side effects compared to a placebo on depression symptoms in Japanese teenagers aged 12 to 17 years with a diagnosis of Major Depressive Disorder (MDD). The overall time eac…
Phase: PHASE3 • Sponsor: Takeda • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
New weekly shot could help control blood sugar in type 2 diabetes
Disease control Not yet recruitingThis is a multicenter, randomized, double-blind, placebo-controlled Phase III clinical study to evaluate the efficacy and safety of HS-20094 injection in subjects with type 2 diabetes who have inadequate glycemic control with diet and exercise alone. The primary objective of this…
Phase: PHASE3 • Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 26, 2026 14:07 UTC
-
Could a 6-Month pill combo beat Drug-Resistant TB?
Disease control Not yet recruitingThis study aims to compare the efficacy and safety of a 6-month all-oral regimen including Bedaquiline (BDQ,B), Delamanid (DLM,D), Linezolid (LZD, L), and Levofloxacin (LFX,L) to the the standard long - course treatment regimen within the Chinese population. The main questions it…
Phase: NA • Sponsor: Wuhan Pulmonary Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Could a common heart pill help those with artificial valves?
Disease control Recruiting nowThis study aims to evaluate the effect of sacubitril/valsartan in patients with prosthetic heart valves with heart failure with reduced ejection fraction (HFrEF).
Phase: NA • Sponsor: Kafrelsheikh University • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New pill aims to calm social anxiety on the spot
Symptom relief OngoingThis is a multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of a single oral dose of VQW-765 compared to placebo in adults with social anxiety disorder.
Phase: PHASE3 • Sponsor: Vanda Pharmaceuticals • Aim: Symptom relief
Last updated Jul 22, 2026 00:00 UTC
-
Which surgery helps women with endometriomas get pregnant faster?
Disease control Recruiting nowThe goal of this clinical trial is to compare pregnancy rates after different surgical treatments for endometriomas in adult women who have one or more ovarian cysts (endometriomas) larger than 2 cm requiring surgery. The main questions it aims to answer are: How many women beco…
Phase: NA • Sponsor: Clinique Tivoli Ducos • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New drug combo trial hopes to tackle advanced cancers
Disease control Recruiting nowThis study is to assess the safety and tolerability, obtain the recommended phase 2 dose(RP2D)/or Maximum Tolerated Dose (MTD) for LM-2417 as a single agent or in combination with other anti-tumour agents in subjects with advanced solid tumours.
Phase: PHASE1, PHASE2 • Sponsor: LaNova Medicines Limited • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Nine classroom lessons that could help children spot abuse
Prevention CompletedBackground: Child maltreatment is a major public health problem with significant medical, legal, and social implications that can result in serious injuries, permanent disabilities, and even death Purpose: This study aimed to evaluate the effectiveness of the Child Sexual Abuse P…
Phase: NA • Sponsor: Tokat Gaziosmanpasa University • Aim: Prevention
Last updated Jul 25, 2026 00:00 UTC
-
ITP showdown: daily pill vs IV infusion in major new trial
Disease control Not yet recruitingThis study is a phase 3 study where eligible patients will be randomized 1:1 to one of two treatment strategies: receiving a thrombopoietin receptor agonist (Avatrombopag), or anti-CD20 (Rituximab).
Phase: PHASE3 • Sponsor: Ostfold Hospital Trust • Aim: Disease control
Last updated Jun 26, 2026 14:30 UTC
-
New eye drug EYE103 aims to restore vision in macular degeneration and vein occlusion
Disease control Recruiting nowEYE-RES-104 is a randomized, dose-masked study of intravitreal EYE103 in participants with neovascular age-related macular degeneration (NVAMD) or macular edema following branch retinal vein occlusion (BRVO). The study will consist of 4 patient cohorts, with participants in each…
Phase: PHASE2 • Sponsor: EyeBiotech Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC